Quantitative U.S. Total Market Equity Portfolio CPRX Holdings History
Total Market Plus Equity Portfolio's Catalyst Pharmaceuticals Inc Holding Summary
As of 2025-04-30, Total Market Plus Equity Portfolio held 32,480.00 shares of Catalyst Pharmaceuticals Inc(CPRX), totaling $788,940.00. This investment constitutes 2.74% of their stock portfolio, and Total Market Plus Equity Portfolio now holds 0.03% of the outstanding Catalyst Pharmaceuticals Inc(CPRX) stock.
The initial trade took place in 2023Q4. And since then Total Market Plus Equity Portfolio has made 1 purchases of CPRX, at an average price of $13.21, for a total of 38,660.00 shares. In addition, there have been 1 sales at an average price of $22.74 for 6,180.00 shares. Based on historical transaction data and CPRX's current price of $21.79, Total Market Plus Equity Portfolio's estimated gain on his CPRX holdings is $337,573.80, reflecting a 66.10% gain to date.
Total Market Plus Equity Portfolio CPRX ($21.79) Holding Chart
Total Market Plus Equity Portfolio CPRX ($21.79) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
